Persistent damage on magnetic resonance enterography in patients with Crohn’s disease in endoscopic remission

In Crohn's disease, it is essential to distinguish between persistent damage and abnormalities that can heal with anti‐inflammatory therapy.

[1]  M. Parkes,et al.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults , 2019, Gut.

[2]  W. Sandborn,et al.  Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease. , 2018, Gastroenterology.

[3]  K. Ohtsuka,et al.  Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn’s Disease , 2018, The American Journal of Gastroenterology.

[4]  I. Ordás,et al.  Autologous Haematopoietic Stem Cell Transplantation for Refractory Crohn’s Disease: Efficacy in a Single-Centre Cohort , 2017, Journal of Crohn's & colitis.

[5]  A. Gonçalves,et al.  Transmural Healing Is Associated with Improved Long-term Outcomes of Patients with Crohn's Disease , 2017, Inflammatory bowel diseases.

[6]  H. Tilg,et al.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management , 2017, Journal of Crohn's & colitis.

[7]  I. Ordás,et al.  Comparison of Diagnostic Accuracy and Impact of Magnetic Resonance Imaging and Colonoscopy for the Management of Crohn's Disease. , 2016, Journal of Crohn's & colitis.

[8]  Nicola Della Valle,et al.  Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn’s disease: correlation with SES-CD and clinical-biological markers , 2016, BMC Medical Imaging.

[9]  H. Ha,et al.  Endoscopic Complete Remission of Crohn Disease After Anti-Tumor Necrosis Factor-α Therapy: CT Enterographic Findings and Their Clinical Implications. , 2016, AJR. American journal of roentgenology.

[10]  Takahito Nakajima,et al.  Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers , 2016, BMC Medical Imaging.

[11]  P. Rutgeerts,et al.  Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation , 2016, Alimentary pharmacology & therapeutics.

[12]  A. Griffiths,et al.  Systematic review with meta‐analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn's disease , 2015, Alimentary pharmacology & therapeutics.

[13]  E. Louis,et al.  Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease. , 2015, Gastroenterology.

[14]  Z. Zeng,et al.  Systematic review with meta‐analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn's disease , 2014, Alimentary pharmacology & therapeutics.

[15]  I. Ordás,et al.  Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. , 2014, Gastroenterology.

[16]  J. Fletcher,et al.  EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging , 2013, The American Journal of Gastroenterology.

[17]  Jeroen A. W. Tielbeek,et al.  Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. , 2013, Journal of Crohn's & colitis.

[18]  Steve Halligan,et al.  Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. , 2012, European journal of radiology.

[19]  Jordi Rimola,et al.  Magnetic resonance imaging for evaluation of Crohn's disease: Validation of parameters of severity and quantitative index of activity , 2011, Inflammatory bowel diseases.

[20]  J. Gisbert,et al.  Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease , 2011, Alimentary pharmacology & therapeutics.

[21]  Stuart A. Taylor,et al.  Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. , 2009, Radiology.

[22]  I. Ordás,et al.  Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease , 2009, Gut.

[23]  Joel G Fletcher,et al.  Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial , 2008, Gastrointestinal endoscopy.

[24]  M. Vatn,et al.  Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. , 2007, Gastroenterology.

[25]  R. Jian,et al.  Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy , 2002, American Journal of Gastroenterology.